Schedule 13D ownership disclosure

Benitec Biopharma Inc

Security class unavailable · CUSIP: 08205P209

Event date: 2024-11-14

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
12,679,779
Percent of class
44.1500%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000899140-24-001285
Form type
SC 13D/A
Filer
Benitec Biopharma Inc.
CIK
CIK 1808898
Filed
Nov 18, 2024
Reporting period
Nov 14, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub